|
Emcure Pharmaceuticals Ltd.
|
COMPANY PROFILE
|
|
|
The profile page of the company captures the details on company's address, top management,
listings, latest financial results.
|
Market Cap. (Rs.)
|
27270.80 Cr.
|
P/BV
|
6.62
|
Book Value (Rs.)
|
217.28
|
|
52 Week High/Low (Rs.)
|
1520/889
|
FV/ML
|
10/1
|
P/E(X)
|
40.03
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
35.94
|
Div Yield (%)
|
0.21
|
|
|
|
Registered & Corporate Office : Plot No. P-1 & P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi,, Pune, Maharashtra - 411057 Tel: 020-35070033, 35070000,Fax: 020-35070060 Website :http://www.emcure.com Email :investors@emcure.com
|
|
Registrar & Share Transfer Agent
|
|
MUFG Intime India Pvt. Ltd. C 101, 247 Park,
L.B.S. Marg, Vikhroli (West), , , Mumbai - 400083, Maharashtra Tel : 022-49186270, 49186200 Fax : 49186060
|
| Name | Designation |
|---|
| Mr. Satish Ramanlal Mehta | Managing Director & CEO |
| Mr. Chetan Rajendra Sharma | Co. Secretary & Compl. Officer |
|
Business Group
|
Not Applicable
|
|
BSE Code
|
544210
|
|
NSE Code
|
EMCUREEQ
|
|
Listings
|
BSE , BSE , NSE
|
|
ISIN No.
|
INE168P01015
|